Skip to main content

Table 1 The characterization of the patient groups

From: Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer

 

Healthy volunteers

Gastric cancer

Recurrent patients

Age (range)

59 y (35 to 86 y)

60 y (36 to 87 y)

64 y (51 to 65 y)

Gender

   

Female

31

35

11

Male

76

77

31

TNM Stage

   

I

 

14

0

II

 

40

13

III

 

39

26

IV

 

19

3

Resection margins

   

R0

 

70

42

R1

 

17

 

R2

 

23